Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Management Advisory Board
View:
Post by Infinity on Jun 05, 2024 6:41am

Management Advisory Board

I am hoping that the Management of TLT will try and expand their Advisory Board to include some real "influenzers" on our Team.  We are going in multiple directions simultaneously.  To really get the benefits of this multi prong approach is get people like Dr. Darwin Kobasa, Dr. Kevin Coombs on the vaccine side and perhaps Doctors who specialize in Brain and Lung cancers.  Ask for their input to meet the guidelines of Health Canada and FDA . Perhaps their new ideas will help us reach the goal of providing an efficient and enduring cure to multiple serious ailments.
Comment by Longholder99 on Jun 05, 2024 9:13am
I suspect that's what Dr Lbiati was supposed to be doing.  Haven't heard much from her yet though.  Maybe her work is behind the scenes and we will see results eventually. 
Comment by plantrader on Jun 05, 2024 11:07am
Do we know that she's still involved? Hopefully she's at least facilitating relationships even if not having any good luck with JV/partnerships/licensing.
Comment by Infinity on Jun 05, 2024 12:21pm
I was thinking more an Advisor who can advance the cause for vaccines to protect. Remain as an unbiased expert.  Dr. Libiati is a Director of the Company, she is being compensated by shares, options etc.  Not really an independant expert.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250